{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T16:36:21Z","timestamp":1780072581627,"version":"3.54.0"},"reference-count":34,"publisher":"Impact Journals, LLC","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2016,2,9]]},"DOI":"10.18632\/oncotarget.6781","type":"journal-article","created":{"date-parts":[[2015,12,31]],"date-time":"2015-12-31T21:26:11Z","timestamp":1451597171000},"page":"6639-6648","source":"Crossref","is-referenced-by-count":19,"title":["Safety and efficacy of sorafenib therapy in patients with hepatocellular carcinoma: final outcome from the Chinese patient subset of the GIDEON study"],"prefix":"10.18632","volume":"7","author":[{"given":"Sheng-Long","family":"Ye","sequence":"first","affiliation":[{"name":"Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoping","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Surgery, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiamei","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Special Treatment, Eastern Hepatobiliary Surgery Hospital, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Bie","sequence":"additional","affiliation":[{"name":"Institute of Hepatobiliary Surgery, Southwest Hospital, Third Military Medical University, Chongqing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuijun","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of General Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengyong","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Interventional Radiology, Chinese PLA General Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luming","family":"Liu","sequence":"additional","affiliation":[{"name":"Shanghai Cancer Center, Fudan University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, Nanfang Hospital of Southern Medical University, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kefeng","family":"Dou","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, Xijing Hospital, Xi'an, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyi","family":"Hao","sequence":"additional","affiliation":[{"name":"Department of Hepato-Pancreato-Biliary Surgery, Beijing Cancer Hospital, Peking University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoliang","family":"Shao","sequence":"additional","affiliation":[{"name":"Department of Radiology, Zhejiang Cancer Hospital, Hangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Xia","sequence":"additional","affiliation":[{"name":"Department of Liver Surgery, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yajin","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, Second Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jijin","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Changhai Hospital, Second Military Medical University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaxing","family":"Deng","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunpeng","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, The First Hospital of China Medical University, Shenyang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunfei","family":"Yuan","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary, Cancer Center, Sun Yat-sen University, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiren","family":"Fu","sequence":"additional","affiliation":[{"name":"Department of Liver Transplantation, Shanghai Changzheng Hospital, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiko","family":"Nakajima","sequence":"additional","affiliation":[{"name":"Global Medical Affairs, Bayer Healthcare Pharmaceuticals, Montville, NJ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina S.M.","family":"Yip","sequence":"additional","affiliation":[{"name":"Medical Affairs Oncology, Bayer Healthcare Company Ltd., Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengguang","family":"Lu","sequence":"additional","affiliation":[{"name":"Medical Affairs Oncology, Bayer Healthcare Company Ltd., Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2015,12,28]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1053\/j.gastro.2011.12.061","article-title":"Epidemiology of viral hepatitis and hepatocellular carcinoma","volume":"142","author":"El-Serag","year":"2012","journal-title":"Gastroenterology"},{"key":"2","unstructured":"Cancer Facts and Figures 2015. American Cancer Society. 2015. Available from: http:\/\/www.cancer.org\/acs\/groups\/content\/@editorial\/documents\/document\/acspc-044552.pdf Accessed Jul 31, 2015."},{"key":"3","unstructured":"Liver Cancer Estimated Incidence, Mortality and Prevalence Worldwide in 2012. GLOBOCAN 2012, World Health Organization Website. Available from: http:\/\/globocan.iarc.fr\/Pages\/fact_sheets_cancer.aspx Accessed August 19, 2015."},{"key":"4","doi-asserted-by":"crossref","first-page":"S206","DOI":"10.1016\/S1590-8658(10)60507-5","article-title":"The changing pattern of epidemiology in hepatocellular carcinoma","volume":"42","author":"El-Serag","year":"2010","journal-title":"Dig Liver Dis"},{"key":"5","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S1470-2045(08)70285-7","article-title":"Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial","volume":"10","author":"Liang","year":"2009","journal-title":"Lancet Oncol"},{"key":"6","doi-asserted-by":"crossref","first-page":"401","DOI":"10.2188\/jea.JE20100190","article-title":"Hepatitis B and C virus infection and hepatocellular carcinoma in China: a review of epidemiology and control measures","volume":"21","author":"Inoue","year":"2011","journal-title":"J Epidemiol"},{"key":"7","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1634\/theoncologist.2010-S4-05","article-title":"The incidence and epidemiology of hepatocellular carcinoma: a global and regional perspective","volume":"15","author":"de Guevara","year":"2010","journal-title":"Oncologist"},{"key":"8","first-page":"38","article-title":"Features and treatment options of Chinese hepatocellular carcinoma","volume":"2","author":"Qin","year":"2013","journal-title":"Chin Clin Oncol"},{"key":"9","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1002\/hep.20790","article-title":"Management of hepatocellular carcinoma","volume":"42","author":"Sherman","year":"2005","journal-title":"Hepatology"},{"key":"10","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1016\/S0140-6736(03)14964-1","article-title":"Hepatocellular carcinoma","volume":"362","author":"Bruix","year":"2003","journal-title":"Lancet"},{"key":"11","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/onc.2008.362","article-title":"CRAF inhibition induces apoptosis in melanoma cells with non-V600E BRAF mutations","volume":"28","author":"Herlyn","year":"2009","journal-title":"Oncogene"},{"key":"12","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1158\/1535-7163.MCT-08-0013","article-title":"Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling","volume":"7","author":"Lynch","year":"2008","journal-title":"Mol Cancer Ther"},{"key":"13","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1097\/CAD.0b013e32835c032f","article-title":"Sorafenib for the treatment of unresectable hepatocellular carcinoma in HIV-positive patients","volume":"24","author":"Tirelli","year":"2013","journal-title":"Anticancer Drugs"},{"key":"14","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/hep.24199","article-title":"Management of hepatocellular carcinoma: an update","volume":"53","author":"Sherman","year":"2011","journal-title":"Hepatology"},{"key":"15","first-page":"779","article-title":"Sorafenib for the treatment of unresectable hepatocellular carcinoma","volume":"2","author":"Furuse","year":"2008","journal-title":"Biologics"},{"key":"16","first-page":"954","article-title":"Efficacy of Sorafenib for Advanced Hepatocellular Carcinoma and Prognostic Factors","volume":"61","author":"Chen","year":"2014","journal-title":"Hepatogastroenterology"},{"key":"17","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1097\/MEG.0b013e3283386053","article-title":"Tolerance and outcome of patients with unresectable hepatocellular carcinoma treated with sorafenib","volume":"22","author":"Degos","year":"2010","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"18","unstructured":"Guidelines for the diagnosis and treatment of primary liver cancer (2011 edition). Ministry of Health of China 2011. Chin Clin Oncol. 2012; 1:10."},{"key":"19","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1056\/NEJMoa0708857","article-title":"Sorafenib in advanced hepatocellular carcinoma","volume":"359","author":"Zeuzem","year":"2008","journal-title":"N Engl J Med"},{"key":"20","doi-asserted-by":"crossref","first-page":"929","DOI":"10.3892\/mco.2015.554","article-title":"Efficacy and adverse events of transcatheter arterial chemoembolization in combination with sorafenib in the treatment of unresectable hepatocellular carcinoma","volume":"3","author":"Li","year":"2015","journal-title":"Mol Clin Oncol"},{"key":"21","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1111\/j.1742-1241.2010.02414.x","article-title":"Design and rationale for the non-interventional Global Investigation of Therapeutic DEcisions in Hepatocellular Carcinoma and Of its Treatment with Sorafenib (GIDEON) study","volume":"64","author":"Kudo","year":"2010","journal-title":"Int J Clin Pract"},{"key":"22","unstructured":"Daniele, Ratziu, Stal, Serejo, Bodoky, Croitoru, et al. Final analysis of European patients from the Global Investigation of Therapeutic Decisions in Hepatocellular Carcinoma and of its Treatment with Sorafenib (GIDEON) study: Baseline characteristics and staging systems. 2014 ASCO Annual Meeting 2015. Available from: http:\/\/meetinglibrary.asco.org\/content\/127583-144. Accessed Aug 1, 2015."},{"key":"23","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/j.1742-1241.2012.02940.x","article-title":"First interim analysis of the GIDEON (Global Investigation of therapeutic decisions in hepatocellular carcinoma and of its treatment with sorafeNib) non-interventional study","volume":"66","author":"Yoon","year":"2012","journal-title":"Int J Clin Pract"},{"key":"24","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/ijcp.12352","article-title":"GIDEON (Global Investigation of therapeutic DEcisions in hepatocellular carcinoma and Of its treatment with sorafeNib): second interim analysis","volume":"68","author":"Nakajima","year":"2014","journal-title":"Int J Clin Pract"},{"key":"25","unstructured":"Marrero, Lencioni, Ye, Kudo, Bronowicki, Chen, et al. Final analysis of GIDEON (Global Investigation of Therapeutic Decisions in Hepatocellular Carcinoma [HCC] and of Its Treatment with Sorafenib [Sor]) in >3000 Sor-treated patients (pts): Clinical findings in pts with liver dysfunction. 2013 ASCO Annual Meeting 2015. Available from: http:\/\/meetinglibrary.asco.org\/content\/116738-132. Accessed Aug 1, 2015."},{"key":"26","unstructured":"EUDRALEX : The rules governing medicinal products in the European Union. European Medical Agency. 2007. Available from: http:\/\/ec.europa.eu\/enterprise\/newsroom\/cf\/itemdetail.cfm?&item_id=897. Accessed Jun 1, 2014."},{"key":"27","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1111\/j.1365-2036.2011.04860.x","article-title":"Safety and efficacy of sorafenib in hepatocellular carcinoma: the impact of the Child-Pugh score","volume":"34","author":"Mathurin","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"28","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1002\/hep.24644","article-title":"Field-practice study of sorafenib therapy for hepatocellular carcinoma: a prospective multicenter study in Italy","volume":"54","author":"Colombo","year":"2011","journal-title":"Hepatology"},{"key":"29","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1007\/s00280-011-1616-x","article-title":"Sorafenib for hepatocellular carcinoma according to Child-Pugh class of liver function","volume":"68","author":"Kang","year":"2011","journal-title":"Cancer Chemother Pharmacol"},{"key":"30","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1634\/theoncologist.2008-0191","article-title":"Sorafenib in unresectable hepatocellular carcinoma from mild to advanced stage liver cirrhosis","volume":"14","author":"Peck-Radosavljevic","year":"2009","journal-title":"Oncologist"},{"key":"31","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1093\/annonc\/mds343","article-title":"Sorafenib in patients with Child-Pugh class A and B advanced hepatocellular carcinoma: a prospective feasibility analysis","volume":"24","author":"Banzi","year":"2013","journal-title":"Ann Oncol"},{"key":"32","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1097\/MCG.0b013e31818ddfc6","article-title":"Safety and efficacy of sorafenib in patients with advanced hepatocellular carcinoma in consideration of concomitant stage of liver cirrhosis","volume":"43","author":"Galle","year":"2009","journal-title":"J Clin Gastroenterol"},{"key":"33","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.2217\/fon.15.163","article-title":"Impact of sorafenib dosing on outcome from the European patient subset of the GIDEON study","volume":"11","author":"Bodoky","year":"2015","journal-title":"Future Oncol"},{"key":"34","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.gastrohep.2014.11.001","article-title":"Therapeutic decisions in the treatment of hepatocellular carcinoma and patterns of sorafenib use. Results of the international observational GIDEON trial in Spain","volume":"38","author":"Arenas","year":"2015","journal-title":"Gastroenterol Hepatol"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.6781","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T17:23:07Z","timestamp":1589217787000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.6781"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12,28]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,2,9]]}},"alternative-id":["6781","26735891"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.6781","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12,28]]}}}